Boltbody ISAC PD-L1 (Bolt Bio)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameBoltbody ISAC PD-L1 (Bolt Bio)

Drug Alias Namedendritic cell-activating anti-PD-L1 antibody (Bolt Biotherapeutics)immune-stimulating antibody conjugates (Bolt Biotherapeutics)anti-PD-L1 TLR7/8 ISAC (Bolt Biotherapeutics)

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)Biologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugateBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody conjugate

Mechanisms of ActionProgrammed death-ligand 1 blockersToll like receptor 8 agonistsToll like receptor 7 agonists

TargetsToll like receptor 8Programmed death-ligand 1Toll like receptor 7

Therapy Area/IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungHead and Neck Neoplasms +[4]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesBolt Biotherapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesBolt Biotherapeutics Inc

Active IndicationsN/A

Inactive IndicationsSolid tumoursCarcinoma, Non-Small-Cell LungHead and Neck Neoplasms +[4]

Other Information

ATC CodeN/A